High Purity Adipotide Peptide 2mg Per Vial Anti-Aging Research Raw Powder
TDS 20 Inquiries
859216-15-2
Research Grade
99.9%
GUANGZHOU
HF
2mg/vial
2026-08-31
peptides
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionHKPao (Hunter-killer peptide ao) is a biologically active peptide. HKPao (Hunter-killer peptide ao) has anti-obesity and anti-tumor pro-apoptotic activity to cause release of cytochrome c from vesicles.CertificatesBasic Info
-
Product Name:
HKPao
Other Name:D-Lysine, L-cysteinyl-L-lysylglycylglycyl-L-arginyl-L-alanyl-L-lysyl-L-α-aspartyl-L-cysteinylglycylglycyl-D-lysyl-D-leucyl-D-alanyl-D-lysyl-D-leucyl-D-alanyl-D-lysyl-D-lysyl-D-leucyl-D-alanyl-D-lysyl-D-leucyl-D-alanyl-;Adipotide Powder;Weight Loss Peptides Adipotide Adipotide Ftpp;HKPao;Adipotide (FTPP) 5mg 10mg;Prohibitin-targeting peptide 1
CAS No.:859216-15-2
Molecular Formula:C111H206N36O28S2
InChIKeys:GZESIPHLGJDZRG-XRIURATCNA-N
Molecular Weight:2557.21
EC Number:200-001-8
Categories:
Characteristics-
Density:
1.40±0.1 g/cm3(Predicted)
Research-
Class:
Chimeric peptidomimetic (fat-targeting vascular disruptor)
Status:Research compound — Not FDA approved, clinical development discontinued
Mechanism:A synthetic chimeric peptide composed of a fat-vascular-targeting cyclic peptide (CKGGRAKDC) linked via a GG spacer to a pro-apoptotic peptide (KLAKLAK)2. Adipotide selectively binds prohibitin in the vasculature of white adipose tissue, then delivers the pro-apoptotic domain to induce vascular disruption, causing fat tissue death. In primate studies (2011), it produced significant weight loss (~11%) but also caused renal toxicity, leading to development discontinuation.
Activity note:Adipotide is not a receptor agonist. It functions as a targeted vascular disruptor. Functional activity is measured by tissue-specific apoptosis, not traditional EC50.
Source:PubChem: Adipotide (CID 163360068); Kolonin MG, et al. Sci Transl Med. 2004;6(148):148ra16.DOI
References-
PubChem:Literature:
Sci Transl Med: Kolonin MG, et al. (2004) — Adipotide mechanism; ChemicalBook: Adipotide (CAS 859216-15-2)
Disclaimer:Adipotide is NOT FDA-approved or EMA-approved. It is a research compound only. Clinical development was discontinued due to renal toxicity observed in primate studies. This listing is for industrial and laboratory research use only. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
peptides
-
Location:
No. 85, Qingnian Road, Hongqiao District, Tianjin
-
Total Annual Revenue:
$5 million-$10 million
-
Total Employees:
51-100
-
Year of Establishment:
2026
-
-
Inquiry History20 Inquiries
Country Product Purchase Quantity Date Posted
United States
Adipotide
10 MG Jun 6, 2025
United States
adipotide
10 May 30, 2025
United States
Adipotide
2 BOU Nov 26, 2024
Germany
Adipotide
100 Nov 6, 2024
Mexico
adipotide
5 G Sep 8, 2025
United States
adipotide
10 MG Aug 21, 2025
United States
adipotide
15 MG Jun 15, 2025
Germany
Adipotide FTPP
200 MG Oct 18, 2024
United States
adipotide
1 KG Feb 24, 2026
Philippines
Adipotide
10 PCS Oct 20, 2025
United States
ADIPOTIDE
100 MG Jul 21, 2025
Thailand
adipotide
100 Apr 23, 2025
United States
Adipotide
10 G Apr 18, 2025
United States
Adipotide
5 G Apr 12, 2025
United States
Adipotide
5 MG Jan 9, 2025
United States
99% Purity Weight Loss Peptide Adipotide for Slimdown
57 KG Nov 30, 2024
United States
Adipotide
500 MG Nov 20, 2024
United States
Adipotide
10 G Sep 25, 2024
United States
Adipotide 5mg 10vial kit
1 MT Feb 25, 2024
United States
Adipotide CAS Weight Loss Peptides 859216-15-2 99% Purity CAS 859216-15-2 5mg 10mg 20mg vials
15 MG Jun 15, 2025 Post an enquiry for this product
